Erratum: Examination of the safety of pediatric vaccine schedules in a non-human primate model: Assessments of neurodevelopment, learning, and social behavior (Environ Health Perspect, (2015), 123, (579-589), 10.1289/ehp.1408257);Examination of the safety of pediatric vaccine schedules in a non-human primate model: Assessments of neurodevelopment, learning, and social behavior

Environmental Health Perspectives

Volumn 123, Issue 6, 2015, Pages 579-589

  Curtis, Britni ^a,b   Liberato, Noelle ^a,b   Rulien, Megan ^a,b   Morrisroe, Kelly ^a,b   Kenney, Caroline ^a,b   Yutuc, Vernon ^a,b   Ferrier, Clayton ^a,b   Nathan Marti, C ^c,i   Mandell, Dorothy ^d,j   Burbacher, Thomas M ^a,b,e   Sackett, Gene P ^a,b,f  

^a Washington National Primate Research Center   (United States)

^b Center on Human Development and Disability   (United States)

^c Abacist Analytics   (United States)

^d Independent Consultant   (United States)

^e Department of Environmental and Occupational Health Sciences ^*  (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g Johnson Center for Child Health and Development   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^j TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID; THIMEROSAL CONTAINING VACCINE; THIOMERSAL; UNCLASSIFIED DRUG; VACCINE; NEUROTOXIN; PRESERVATIVE;

ARTICLE; BEHAVIOR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOSAGE SCHEDULE COMPARISON; DRUG SAFETY; INFANT; LATENT PERIOD; LEARNING; MALE; NERVE CELL DIFFERENTIATION; NEUROLOGIC EXAMINATION; NONHUMAN; OBJECT CONCEPT PERMANENCE TESTING; PRIORITY JOURNAL; RHESUS MONKEY; SOCIAL BEHAVIOR; ANIMAL; ANIMAL MODEL; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNIZATION; MENTAL DISEASE;

ANIMALIA; MACACA MULATTA; PRIMATES;

ANIMALS; CASE-CONTROL STUDIES; IMMUNIZATION SCHEDULE; LEARNING; MACACA MULATTA; MALE; MODELS, ANIMAL; NEURODEVELOPMENTAL DISORDERS; NEUROTOXINS; PRESERVATIVES, PHARMACEUTICAL; SOCIAL BEHAVIOR; THIMEROSAL; VACCINES;

EID: 84930520021     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.124-A11     Document Type: Erratum

References (84)

1. Atkinson J. 1979. The development of opto kinetic nystagmus in the human infant and monkey infant: an analogue to development in kittens. In: Developmental Neurobiology of Vision (Freeman RD). NATO Advanced Study Institutes Series, Vol. 27. Boston, MA:Springer, 277–287.
2. Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW. 2012. Thimerosal exposure in early life and neuro psychological outcomes 7–10 years later. J Pediatr Psychol 37:106–118.
3. Bauer DJ, Curran PJ. 2005. Probing interactions in fixed and multilevel regression: inferential and graphical techniques. Multivariate Behav Res 40:373–400.
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Methodol 57:289–300.
5. Berman RF, Pessah IN, Mouton PR, Mav D, Harry J. 2008. Low-level neonatal thimerosal exposure: further evaluation of altered neuro toxic potential in SJL mice. Toxicol Sci 101:294–309.
6. Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G. 2003. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan. Pediatrics 111(6 Pt 1):e645–649.
7. Boothe RG, Dobson V, Teller DY. 1985. Postnatal develop ment of vision in human and nonhuman primates. Ann Rev Neurosci 8:495–545.
8. Boothe RG, Williams RA, Kiorpes L, Teller DY. 1980. Development of contrast sensitivity in infant Macaca nemestrina monkeys. Science 208:1290–1292.
9. Bowman RE, Schantz SL, Gross ML, Ferguson SA. 1989. Behavioral effects in monkeys exposed to 2,3,7,8-TCDD transmitted maternally during gestation and for four months of nursing. Chemosphere 18:235–242.
10. Brazelton TB. 1978. The Brazelton Neonatal Behavior Assessment Scale: introduction. Monogr Soc Res Child Dev 43(5-6):1-13.
11. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. 2002. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 51(RR-3):1–31.
12. Burbacher TM, Grant KS. 2000. Methods for studying nonhuman primates in neuro behavioral toxicology and teratology. Neurotoxicol Teratol 22:475–486.
13. Burbacher TM, Grant KS. 2012. Measuring infant memory: utility of the visual paired-comparison test paradigm for studies in developmental neuro-toxicology. Neurotoxicol Teratol 34:473–480.
14. Burbacher TM, Grant KS, Mottet NK. 1986. Retarded object permanence development in methylmercury exposed Macaca fascicularis infants. Develop Psychol 22:771–776.
15. Burbacher TM, Grant KS, Worlein J, Ha J, Curnow E, Juul S, et al. 2013. Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center. Am J Primatol 75:1063–1083.
16. Burbacher TM, Sackett GP, Mottet NK. 1990. Methylmercury effects on the social behavior of Macaca fascicularis infants. Neurotoxicol Teratol 12:65–71.
17. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. 2005. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 113:1015–1021; doi:10.1289/ehp.7712.
18. Bushnell PJ, Bowman RE. 1979. Effects of chronic lead ingestion on social development in infant rhesus monkeys. Neurobehav Toxicol 1:207–219.
19. CDC (Centers for Disease Control and Prevention). 1999. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 48:563–565.
20. Center on Human Development and Disability. 2009. Infant Primate Research Laboratory: Testing Equipment, Protocols and Experienced Laboratory Personnel. Available: http://depts.washington.edu/iprl/iprl_testing.html [accessed 30 April 2015].
21. Chamove AS, Molinaro TJ. 1978. Monkey retardate learning analysis. J Ment Defic Res 22:37–48.
22. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. 2002. Retinal degeneration mutants in the mouse. Vision Res 42:517–525.
23. Clements CJ, Ball LK, Ball R, Pratt D. 2000. Thiomersal in vaccines. Lancet 355:1279–1280.
24. Davidson PW, Sloane-Reeves J, Myers GJ, Hansen ON, Huang LS, Georger LA, et al. 2008. Association between prenatal exposure to meth-ylmercury and visuospatial ability at 10.7 years in the Seychelles Child Development Study. Neurotoxicology 29:453–459.
25. Diamond A. 1990. The development and neural bases of memory functions as indexed by the AB and delayed response tasks in human infants and infant monkeys. Ann NY Acad Sci 608:267–309.
26. Dórea JG, Farina M, Rocha JB. 2013. Toxicity of ethyl-mercury (and thimerosal): a comparison with methyl mercury. J App Toxicol 33:700–711.
27. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. 2008. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57(RR07):1–60.
28. Gilbert SG, Burbacher TM, Rice DC. 1993. Effects of in utero methylmercury exposure on a spatial delayed alternation task in monkeys. Toxicol Appl Pharmacol 123:130–136.
29. Golub MS. 1990. Use of monkey neonatal neuro-behavioral test batteries in safety testing protocols. Neurotoxicol Teratol 12:537–541.
30. Gunderson VM, Grant-Webster KS, Burbacher TM, Mottet NK. 1988. Visual recognition memory deficits in methylmercury-exposed Macaca fascicularis infants. Neurotoxicol Teratol 10:373–379.
31. Gunderson VM, Sackett GP. 1984. Development of pattern recognition in infant pigtailed macaques (Macaca nemestrina). Dev Psychol 20:412–426.
32. Gust DA, Kennedy A, Weber D, Evans G, Kong Y, Salmon D. 2009. Parents questioning immunization: evaluation of an intervention. Am J Health Behav 33:287–298.
33. Harlow HF. 1959. The development of learning in the rhesus monkey. Am Sci 47:459–479.
34. Harlow HF, Bromer JA. 1938. A test apparatus for monkeys. Psychol Rec 2:434–436.
35. Harry GJ, Harris MW, Burka LT. 2004. Mercury concen-trations in brain and kidney following ethylmercury, methylmercury and thimerosal administration to neonatal mice. Toxicol Lett 154:183–189.
36. Heron J, Golding J, ALSPAC Study Team. 2004. Thimerosal exposure in infants and develop mental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114:577–583.
37. Hewitson L, Houser LA, Stott C, Sackett G, Tomko JL, Atwood D, et al. 2010a. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. J Toxicol Environ Health A 73:1298–1313.
38. Hewitson L, Lopresti BJ, Stott C, Mason NS, Tomko J. 2010b. Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: a pilot study. Acta Neurobiol Exp (Wars) 70:147–164.
39. Hornig M, Chian D, Lipkin WI. 2004. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9:833–845.
40. Jones B, Mishkin M. 1972. Limbic lesions and the problem of stimulus–reinforcement associations. Exp Neurol 36:362–377.
41. Kempe A, Daley MF, McCauley MM, Crane LA, Suh CA, Kennedy AM, et al. 2011. Prevalence of parental concerns about childhood vaccines: the experi-ence of primary care physicians. Am J Prev Med 40:548–555.
42. Laurente J, Remuzgo F, Ávalos B, Chiquinta J, Ponce B, Avendaño R, et al. 2007. Neurotoxic effects of thimerosal at vaccine doses on the encephalon and development in 7 days-old hamsters. An Fac Med Lima 68:222–237.
43. Levin ED, Schneider ML, Ferguson SA, Schantz SL, Bowman RE. 1988. Behavioral effects of develop-mental lead exposure in rhesus monkeys. Dev Psychobiol 21:371–382.
44. Li X, Qu F, Xie W, Wang F, Liu H, Song S, et al. 2014. Transcriptomic analyses of neuro toxic effects in mouse brain after intermittent neonatal administration of thimerosal. Toxicol Sci 139:452–465.
45. Llop S, Lopez-Espinosa MJ, Rebagliato M, Ballester F. 2013. Gender differences in the neuro toxicity of metals in children. Toxicology 311:3–12.
46. Mandell DJ, Sackett GP. 2008. A computer touch screen system and training procedure for use with primate infants: results from pigtail monkeys (Macaca nemestrina). Dev Psychobiol 50:160–170.
47. Mandell DJ, Sackett GP. 2009. Comparability of developmental cognitive assessments between standard and computer testing methods. Dev Psychobiol 51:1–13.
48. Mandell DJ, Unis A, Sackett GP. 2011. Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys. Psychopharmacology (Berl) 215:345–352.
49. Mandell DJ, Ward SE. 2011. Building the blocks of execu tive functioning: differentiating early developing processes contributing to executive functioning skills. Dev Psychobiol 53:796–805.
50. Mrozek-Budzyn D, Majewska R, Kieltyka A, Augustyniak M. 2012. Neonatal exposure to thimero sal from vaccines and child development in the first 3 years of life. Neurotoxicol Teratol 34:592–597.
51. Muthén LK, Muthén BO. 2012. Mplus User’s Guide. 7th ed. Los Angeles, CA:Muthén & Muthén. Available: http://www.statmodel.com/download/usersguide/Mplus%20user%20guide%20Ver_7_r6_web.pdf [accessed 30 April 2015].
52. National Center for Health Statistics, in collaboration with the National Center for Chronic Disease Prevention and Health Promotion. 2001. Birth to 36 Months: Boys. Length-for-Age and Weight-for-Age Percentiles. Available: http://www.cdc.gov/growthcharts/data/set1clinical/cj41c017.pdf [accessed 23 January 2015].
53. National Research Council. 2011. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC:National Academies Press. Available: http://www.nap.edu/openbook.php?record_id=12910 [accessed 30 April 2015].
54. Nelson EE, Winslow JT. 2009. Non-human primates: model animals for developmental psycho pathology. Neuropsychopharmacology 34:90–105.
55. Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. 2009. Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res 1301:143–151.
56. Olczak M, Duszczyk M, Mierzejewski P, Meyza K, Majewska MD. 2011. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats. Behav Brain Res 223:107–118.
57. Overman WH, Bachevalier J, Schuhmann E, Ryan P. 1996. Cognitive gender differences in very young children parallel biologically based cognitive gender differences in monkeys. Behav Neurosci 110:673–684.
58. Patten AR, Fontaine CJ, Christie BR. 2014. A compari son of the different animal models of fetal alcohol spectrum disorders and their use in studying complex behaviors. Front Pediatr 2:93; doi:10.3389/fped.2014.00093.
59. Piaget J. 1954. The development of time concepts in the child. Proc Annu Meet Am Psychopathol Assoc 1954–1955:34–44.
60. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. 2002. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 360:1737–1741.
61. Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, et al. 2008. Mercury levels in newborns and infants after receipt of thimerosalcontaining vaccines. Pediatrics 121:e208–e214.
62. Rice DC. 1987. Primate research: relevance to human learning and development. Dev Pharmacol Ther 10:314–327.
63. Rice DC. 1992. Effects of pre-plus postnatal exposure to methylmercury in the monkey on fixed interval and discrimination reversal performance. Neurotoxicology 13:443–452.
64. Rice DC. 1999. Behavioral impairment produced by low-level postnatal PCB exposure in monkeys. Environ Res 80(2 Pt 2):S113–S121.
65. Rice DC, Hayward S. 1997. Effects of postnatal exposure to a PCB mixture in monkeys on non spatial discrimination reversal and delayed alternation performance. Neurotoxicology 18:479–494.
66. Rodrigues JL, Serpeloni JM, Batista BL, Souza SS, Barbosa F Jr. 2010. Identification and distribution of mercury species in rat tissues following adminis tration of thimerosal or methylmercury. Arch Toxicol 84:891–896.
67. Ruppenthal GC. 1985. Weight gain and intake requirements in nursery-reared macaques. In: Proceedings of the 4th Annual Dr. Scholl Conference on the Nutrition of Captive Wild Animals (Meehan TP, Allen ME, eds). Chicago:Lincoln Park Zoological Society, 20–35.
68. Sackett GP, Ruppenthal G, Elias K, eds. 2006a. Nursery Rearing of Nonhuman Primates in the 21st Century. New York:Springer.
69. Sackett G, Ruppenthal G, Hewitson L, Simerly C, Schatten G. 2006b. Neonatal behavior and infant cognitive development in rhesus macaques produced by assisted reproductive technologies. Dev Psychobiol 48:243–265.
70. Sackett GP, Stephenson E, Ruppenthal GC. 1973. Digital data acquisition systems for observing behavior in laboratory and field settings. Behav Res Methods Instrum 5:344–348.
71. Schneider ML, Moore CF, Adkins MM. 2011. The effects of prenatal alcohol exposure on behavior: rodent and primate studies. Neuropsychol Rev 21:186–203.
72. Schneider ML, Suomi SJ. 1992. Neurobehavioral assessment in rhesus monkey neonates (Macaca mulatta): developmental changes, behavioral stability, and early experience. Infant Behav Dev 15:155–177.
73. Schrier AM. 1984. Learning how to learn: the signifi-cance and current status of learning set formation. Primates 25:95–102.
74. Sulkowski ZL, Chen T, Midha S, Zavacki AM, Sajdel-Sulkowska EM. 2012. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex-and strain-dependent effects. Cerebellum 11:575–586.
75. Teller DY, Morse R, Borton R, Regal D. 1974. Visual acuity for vertical and diagonal gratings in human infants. Vision Res 14:1433–1439.
76. Therneau TM, Grambsch PM. 2000. Modeling Survival Data: Extending the Cox Model. New York:Springer.
77. Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, et al. 2007. Early thimero sal exposure and neuro psychological outcomes at 7 to 10 years. N Engl J Med 357:1281–1292.
78. Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D’Elia L, Chiarotti F, et al. 2009. Neuropsychological perfor-mance 10 years after immunization in infancy with thimerosal-containing vaccines. Pediatrics 123:475–482.
79. U.S. Environmental Protection Agency. 1997. Mercury Study Report to Congress. EPA-452/R-97-007. Available: http://www.epa.gov/mercury/report.htm (accessed 23 January 2015).
80. U.S. Food and Drug Administration. 2012. Thimerosal in Vaccines. Available: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm096228.htm [accessed 5 May 2015].
81. Williams AE. 1979. A Longitudinal Study of Object Concept Development in Pigtail Macaques (Macaca nemestrina) [PhD Dissertation]. Seattle, WA:University of Washington. Dissertation Abstracts International, 40, 2868B (University Microfilms 7927889).
82. Wong AA, Brown RE. 2006. Visual detection, pattern discrimination and visual acuity in 14 strains of mice. Genes Brain Behav 5:389–403.
83. Worlein JM, Sackett GP. 1997. Social development in nursery-reared pigtailed macaques (Macaca nemestrina). Am J Primatol 41:23–35.
84. Zareba G, Cernichiari E, Hojo R, Nitt SM, Weiss B, Mumtaz MM, et al. 2007. Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury. J Appl Toxicol 27:511–518.